Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets
Vaccine , Volume 29 - Issue 11 p. 2120- 2126
In the context of an A/H1N1 influenza pandemic situation, this study demonstrates that heterologous vaccination with an AS03-adjuvanted 2008/2009 seasonal trivalent and pandemic H5N1 monovalent split vaccine conferred partial protection in influenza-naïve ferrets after challenge with the influenza pandemic H1N1 A/The Netherlands/602/09 virus. Further, unlike saline control and non-adjuvanted vaccine, it was shown that immunization of naïve ferrets with an AS03-adjuvanted pandemic H1N1 A/California/7/09 influenza split vaccine induced increased antibody response and enhanced protection against the challenge strain, including significant reduction in viral shedding in the upper respiratory tract and reduced lung pathology post-challenge. These results show the need for vaccination with the adjuvanted vaccine to fully protect against viral replication and influenza disease in unprimed ferrets.
|, , , , , , , , , , , , , , , , , , , , ,|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Baras, B, de Waal, L, Stittelaar, K.J, Jacob, V, Giannini, S, Veldhuis Kroeze, E.J.B, … Osterhaus, A.D.M.E. (2011). Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets. Vaccine, 29(11), 2120–2126. doi:10.1016/j.vaccine.2010.12.125